TOP TIERMARKET NEWSWIRE
SEC Form 4 history

TARSUS PHARMACEUTICA (TARS) insider trades

TARSUS PHARMACEUTICA (TARS) insider trading activity (SEC Form 4). Over the trailing 90 days, TARS insiders filed 0 purchases totalling $0 and 5 sales totalling $4.3M — net SELLING of $4.3M. Most recent filing: Sep 17, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
5
$4.3M
Net (90d)
-$4.3M
net selling
Most recent
Sep 17, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 17, 2026Link William J PhdDirS SaleOE—$78.38$980Kfiling
Sep 9, 2026Azamian Bobak R.Pres, CEO, Board ChairS Sale—$90.56$906Kfiling
Sep 9, 2026Neervannan SeshadriCOOS Sale—$85.00$388Kfiling
Sep 9, 2026Lin Elizabeth YeuChief Medical OfficerS Sale—$87.50$1.2Mfiling
Sep 3, 2026Azamian Bobak R.Pres, CEO, Board ChairS Sale—$80.06$801Kfiling
Jun 22, 2026Azamian Bobak R.Pres, CEO, Board ChairS Sale—$61.55$615Kfiling
Jun 17, 2026Farrow Jeffrey SSee RemarksS SaleOE—$60.95$877Kfiling
Jun 17, 2026Link William J PhdDirS Sale—$62.12$776Kfiling
Jun 17, 2026Goodrich KatherineDirS Sale—$62.08$183Kfiling